Concepedia

Emily K. Bergsland

EK

Statistics

Publications

102

Citations

13.4K

H-Index

46

Active since

1997

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Emily K. Bergsland is an author at University of California, San Francisco specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

1997–2025

102

Publications

102

Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer

Fairooz F. Kabbinavar, Herbert I. Hurwitz, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2002 · 1.7K citations

, , +13

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

Gabriele Bergers, Steven Song, Nicole Meyer-Morse et al. · Journal of Clinical Investigation · 2003 · 1.2K citations · Full text

, , +17

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

Gabriele Bergers, Steven Song, Nicole Meyer-Morse et al. · Journal of Clinical Investigation · 2003 · 1.2K citations

, , +17

Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer

Fairooz F. Kabbinavar, Julie Hambleton, R. Mass et al. · Journal of Clinical Oncology · 2005 · 689 citations

, , +14

Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors

Matthew H. Kulke, Heinz‐Josef Lenz, Neal J. Meropol et al. · Journal of Clinical Oncology · 2008 · 620 citations · Full text

, , +16

1–5 of 102